Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine vs desloratadine in chronic idiopathic urticaria
2005-000358-65Phase 4Completed
- Sponsor
- UCB
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic idiopathic urticaria (CIU) comparing Levocetirizine 5 mg with Desloratadine 5 mg (2 arms). Primary endpoint: Primary clinical efficacy comparison. Started Sep 2005; status: completed.
02
Drugs
levocetirizinedesloratadine
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on 2005-000358-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000358-65.